Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer
晚期结直肠癌伊立替康、卡培他滨和塞来昔布减量方案的II期研究
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-007-0472-1
El-Rayes, Bassel F; Zalupski, Mark M; Manza, Stephanie G; Rusin, Barbara; Ferris, Ann Marie; Vaishampayan, Ulka; Heilbrun, Lance K; Venkatramanamoorthy, Raghu; Shields, Anthony F; Philip, Philip A